Pressure BioSciences's latest marketcap:
As of 08/02/2025, Pressure BioSciences's market capitalization has reached $4,297. According to our data, Pressure BioSciences is the 49728th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4,297 |
| Revenue (ttm) | 1.5 M |
| Net Income (ttm) | -33,252,878 |
| Shares Out | 42.97 M |
| EPS (ttm) | -0.89 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/18/2025 |
Pressure BioSciences's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/02/2025 | $4,297 | -97% | 49728 |
| 12/31/2024 | $143,385 | -98.15% | 48188 |
| 12/29/2023 | $7.77 M | -51.1% | 46514 |
| 12/30/2022 | $15.89 M | -13.44% | 44779 |
| 12/31/2021 | $18.35 M | 120.88% | 42758 |
| 12/31/2020 | $8.31 M | 177.01% | 39540 |
| 12/31/2019 | $3 M | -23.9% | 36839 |
| 12/31/2018 | $3.94 M | -13.73% | 35449 |
| 12/29/2017 | $4.57 M | -25.99% | 33925 |
| 12/30/2016 | $6.17 M | -15.49% | 31903 |
Company Profile
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. is a global leader in developing and commercializing high-pressure technology-based instruments, consumables, and services for the life sciences and other industries.
Technology Platforms
- Ultra Shear Technology: Converts hydrophobic oil-based supplements and therapeutics into water-soluble, bioavailable nanoemulsions.
- BaroFold Technology: Enhances protein biotherapeutics quality while reducing production costs.
- Pressure Cycling Technology (PCT): Controls biomolecular interactions using alternating hydrostatic pressure cycles for sample preparation.
Product Offerings
Instrumentation:
- Barocycler 2320EXT, HUB440, HUB880
- Shredder SG3
- UltraShear Mini, K45, Max
Consumables & Kits:
- PCT MicroTubes, MicroCaps, Micro Pestle
- Application-specific kits
Additional Solutions
The company also provides products in:
- Pain relief
- Skincare
- Personal wellness
- Athletic recovery
- Specialized pet care
Key Customers & Collaborations
Serving researchers at:
- Academic & government laboratories
- Biotech & pharmaceutical companies
- Food/beverage labs
Collaborations include:
- RedShiftBio Inc.
- Inova Schar Cancer Center
- NYU, Leica Microsystems, The Ohio State University
- University of Delaware, Cedars Sinai Medical Center
Company Background
Founded in 1978 (formerly Boston Biomedica, Inc.), the company rebranded as Pressure BioSciences, Inc. in 2014. Headquartered in Canton, Massachusetts.
Frequently Asked Questions
-
What is Pressure BioSciences's (OTC-PBIO) current market cap?As of 08/02/2025, Pressure BioSciences (including the parent company, if applicable) has an estimated market capitalization of $4,297 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Pressure BioSciences (OTC-PBIO) rank globally by market cap?Pressure BioSciences global market capitalization ranking is approximately 49728 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.